In reference to the nature of ROS behavior as a double-edged sword, even though several studies have documented the benefits of antioxidant drugs for cancer therapies, none has been supported by solid trials performed on a large scale 153,154
x.prof 011 caffeine ACTIVES PROFESSIONAL SOLUTIONS Treatment area bodyType of skin allformat 20 x 2 mlView product x.prof 012 L-carnitine Metabolisation of fatty acids
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Infiltrating immune cells and pro-inflammatory cytokines decreased
Although BPC 157 lacks general standard neurotransmitter criteria, in classic terms, particular evidence of a consistent beneficial effect shows that BPC 157 therapy counteracts dopamine, serotonin, glutamate, GABA, adrenalin/noradrenalin, acetylcholine, and NO-system disturbances